|
DBT: Financial statement correction due to reissuing audit report 2013
Ben Tre
Pharmaceutical JSC announces the financial statement correction due to
reissuing audit report 2013 approved on 27 March 2014 as follows:
DTL Auditing
Co., Ltd conducted auditing financial statement of fiscal year 2013 of Ben Tre
Pharmaceutical JSC and issued independent audit report No.14.121/BCKT-DTL dated
10 Mar. 2014 stating its opinions on the Company’s financial statement
By the time,
the Company defined the voting rate of the Company at Meyer joint-venture – BPC
was 50% so the Company did not make consolidated financial statement.
Therefore, the financial statement of the Company was supplemented with the
followings:
- Adding
indicator “Profit (Loss)/share” to operating result of the Company.
- Adding
indicator “Profit (Loss)/share” and “Division report” to the Interpretation for
financial statement
Since the
Company submitted the audit report to State Securities Commission and disclosed
the audit report, DTL Auditing Co., Ltd would reissue another audit report to
replace the issued audit report and would announce the audit report No.
14.121/BCKT-DTL dated 10 Mar. 2014 was invalid.
HNX
|
